文献速递生殖医学

抗苗勒管激素水平预测多囊卵巢综合征女性接受克罗米芬和二甲双胍治疗后的排卵

Antimüllerian hormone level predicts ovulation in women with polycystic ovary syndrome treated with clomiphene and metformin.
PubMed 文献 · Fertil Steril · 2023-12-26

该研究为一项随机对照试验的二次分析,纳入333例因多囊卵巢综合征(PCOS)导致无排卵性不孕的女性,评估基线抗苗勒管激素(AMH)水平与排卵、妊娠及活产率的关系。结果显示,基线AMH每升高1 ng/mL,排卵几率降低10%(OR 0.90,95%CI 0.86-0.93),且该效应在各治疗组间无差异;高AMH(>8 ng/mL)者排卵几率显著低于正常AMH(<4 ng/mL)者(OR 0.23,95%CI 0.05-0.68)。基线AMH与妊娠或活产率无显著关联。

要点

  • 基线AMH每升高1 ng/mL,排卵几率降低10%(OR 0.90,95%CI 0.86-0.93)。
  • 高AMH(>8 ng/mL)者排卵几率显著低于正常AMH(<4 ng/mL)者(OR 0.23,95%CI 0.05-0.68)。
  • 基线AMH与妊娠或活产率无显著关联。

核心结论

  • 在因PCOS导致不孕的女性中,较高的AMH浓度与克罗米芬、克罗米芬+二甲双胍及二甲双胍诱导排卵的排卵几率降低相关。

研究设计与样本

  • 研究设计为随机对照试验的二次分析,纳入333例因PCOS导致无排卵性不孕的女性,其中322例有基线AMH浓度数据。

主要发现

  • 基线AMH平均值为11.7 ± 8.3 ng/mL(范围0.1-43.0 ng/mL)。
  • 基线AMH每升高1 ng/mL,排卵几率降低10%(OR 0.90,95%CI 0.86-0.93),该效应在各治疗组间无差异。
  • 高基线AMH(>8 ng/mL)者排卵几率显著低于正常基线AMH(<4 ng/mL)者(OR 0.23,95%CI 0.05-0.68),控制年龄、BMI、研究时间及HOMA-IR评分等混杂因素后仍显著。
  • 即使AMH浓度极高,仍有排卵发生,未观察到无排卵事件发生的最高AMH水平。
  • 控制混杂因素后,基线AMH浓度与妊娠或活产率无显著关联。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the serum anti-Müllerian hormone (AMH) concentrations in a large, well-phenotyped cohort of women with polycystic ovary syndrome (PCOS) and evaluate whether AMH predicts successful ovulation induction in women treated with clomiphene and metformin. DESIGN: Secondary analysis of randomized controlled trial. SETTING: Not applicable. PATIENT(S): A total of 333 women with anovulatory infertility attributed to PCOS who participated in the double-blind randomized trial entitled the Pregnancy in Polycystic Ovary Syndrome I (PPCOS I) study (registration number, NCT00068861) who had serum samples from baseline laboratory testing available for further serum analysis were studied. INTERVENTION(S): Not applicable. MAIN OUTCOME MEASURE(S): The association between the baseline AMH levels in each of the 3 treatment groups and ovulation, pregnancy, and live birth rates were assessed. RESULT(S): A total of 322 individuals had a baseline AMH concentration available, of which the mean AMH was 11.7 ± 8.3 ng/mL (range 0.1-43.0 ng/mL). With each unit (1 ng/mL) increase in baseline AMH, the odds of ovulation decreased by 10% (odds ratio, 0.90; 95% confidence interval, 0.86-0.93); this effect did not differ by treatment group. Women with a high baseline AMH concentration (>8 ng/mL) were significantly less likely to ovulate compared with those with a normal baseline AMH concentration (<4 ng/mL) (odds ratio, 0.23; 95% confidence interval, 0.05-0.68). This remained statistically significant when controlling for confounders, including age, body mass index, time in study, and Homeostatic Model Assessment for Insulin Resistance score. Ovulation occurred even at very high AMH concentrations; there was no maximum level noted at which no ovulation events occurred. Baseline AMH concentration was not associated with pregnancy or live birth rates when controlling for confounders. CONCLUSION(S): These AMH values in well-phenotyped individuals with PCOS add to the literature and will aid in identifying AMH criteria for the diagnosis of PCOS. In women with infertility and PCOS, a higher AMH concentration was associated with reduced odds of ovulation with ovulation induction with clomiphene, clomiphene + metformin, and metformin. CLINICAL TRIAL REGISTRATION NUMBER: The original trial from which this analysis is derived was entitled "Pregnancy in Polycystic Ovary Syndrome: A 30 Week Double-Blind Randomized Trial of Clomiphene Citrate, Metformin XR, and Combined Clomiphene Citrate/Metformin XR For the Treatment of Infertility in Women With Polycystic Ovary Syndrome" and was registered on ClinicalTrials.gov as number NCT00068861. The URL for the trial is https://clinicaltrials.gov/study/NCT00068861. The first subject was enrolled in November 2002.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Komorowski AS, Hughes L, Sarkar P, et al. Antimüllerian hormone level predicts ovulation in women with polycystic ovary syndrome treated with clomiphene and metformin. Fertil Steril. 2023. PMID: 38154770. doi:10.1016/j.fertnstert.2023.12.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。